5 Best Cancer Stocks To Buy Now

2. AbbVie Inc. (NYSE:ABBV)

Number of Hedge Fund Holders: 82

AbbVie Inc. (NYSE:ABBV) is the second-best cancer stock to buy now with $1.82 billion revenue from its hematologic oncology segment in Q2 2021. The company’s cancer drug, Imbruvica, contributed $1.38 billion to the total revenue. Overall, AbbVie Inc.’s (NYSE:ABBV) revenue in the second quarter came in at $13.9 billion, an increase of 33.9% year over year. 

AbbVie Inc. (NYSE:ABBV) is a dividend aristocrat that increased its dividend payment for the last 49 years. The company offers a high dividend yield of 4.76%. Shares of AbbVie Inc. (NYSE:ABBV) increased 29% in the past twelve months.

As of the end of the second quarter, 82 hedge funds tracked by Insider Monkey reported owning stakes in AbbVie Inc. (NYSE:ABBV). The total worth of these stakes is $5.35 billion.